Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hartley

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Cancer|December 12, 2022
The role of PPARγ in prostate cancer development and progressionAndrew Hartley, Imran Ahmad
Psychological Reports|April 4, 2014
College residential sleep environmentKathy Sexton-Radek, Andrew Hartley
Expert Opinion on Drug Discovery|September 16, 2020
Targeting the BAF complex in advanced prostate cancerAndrew Hartley, Hing Y Leung, Imran Ahmad
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 10, 2013
Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemoradiation schedules in head and neck cancerSara Meade, Paul Sanghera, John Glaholm, et al.
The Lancet. Oncology|March 9, 2004
Cancer of the anal canalMatthew A Clark, Andrew Hartley, J Ian Geh
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2009
Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancerAndrew Chan, Daren Teoh, Paul Sanghera, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Modeling the contribution of synchronous chemotherapy to the rate of grade 3 and 4 mucositis in locally advanced squamous cell carcinoma of the head and neckAndrew Hartley, Paul Sanghera, John Glaholm, et al.
Medicines (Basel, Switzerland)|June 30, 2018
Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal CancerAgostino Cristaudo, Mitchell Hickman, Charles Fong, et al.
Journal of Medical Imaging and Radiation Oncology|November 29, 2013
Revised radiobiological modelling of the contribution of synchronous chemotherapy to the rate of grades 3-4 mucositis in head and neck cancerSara Meade, Chris McConkey, Paul Sanghera, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2015
Is 5-year feeding tube dependency a mixed consequential late effect? In regard to Beitler et alCheng Boon, Sara Meade, Helen Benghiat, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Cancer|December 12, 2022
The role of PPARγ in prostate cancer development and progressionAndrew Hartley, Imran Ahmad
Psychological Reports|April 4, 2014
College residential sleep environmentKathy Sexton-Radek, Andrew Hartley
Expert Opinion on Drug Discovery|September 16, 2020
Targeting the BAF complex in advanced prostate cancerAndrew Hartley, Hing Y Leung, Imran Ahmad
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 10, 2013
Models of acute mucosal tolerance to radiotherapy alone applied to synchronous chemoradiation schedules in head and neck cancerSara Meade, Paul Sanghera, John Glaholm, et al.
The Lancet. Oncology|March 9, 2004
Cancer of the anal canalMatthew A Clark, Andrew Hartley, J Ian Geh
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 16, 2009
Radiotherapy compliance is maintained with hypofractionation and concurrent cetuximab in locally advanced head and neck cancerAndrew Chan, Daren Teoh, Paul Sanghera, et al.
International Journal of Radiation Oncology, Biology, Physics|August 22, 2009
Modeling the contribution of synchronous chemotherapy to the rate of grade 3 and 4 mucositis in locally advanced squamous cell carcinoma of the head and neckAndrew Hartley, Paul Sanghera, John Glaholm, et al.
Medicines (Basel, Switzerland)|June 30, 2018
Assessing Novel Drugs and Radiation Technology in the Chemoradiation of Oropharyngeal CancerAgostino Cristaudo, Mitchell Hickman, Charles Fong, et al.
Journal of Medical Imaging and Radiation Oncology|November 29, 2013
Revised radiobiological modelling of the contribution of synchronous chemotherapy to the rate of grades 3-4 mucositis in head and neck cancerSara Meade, Chris McConkey, Paul Sanghera, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2015
Is 5-year feeding tube dependency a mixed consequential late effect? In regard to Beitler et alCheng Boon, Sara Meade, Helen Benghiat, et al.
Pageof 4